Free Trial

Tyra Biosciences (TYRA) News Today

Tyra Biosciences logo
$9.10 +0.28 (+3.17%)
As of 10:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TYRA Latest News

Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Now Covered by Piper Sandler
Piper Sandler began coverage on shares of Tyra Biosciences in a report on Wednesday. They set an "overweight" rating and a $33.00 price objective on the stock.
Tyra Biosciences, Inc. stock logo
HC Wainwright Has Optimistic Outlook of TYRA FY2025 Earnings
Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Analysts at HC Wainwright raised their FY2025 earnings per share (EPS) estimates for shares of Tyra Biosciences in a research report issued on Monday, May 19th. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($2.27) pe
Tyra Biosciences, Inc. stock logo
Equities Analysts Offer Predictions for TYRA FY2026 Earnings
Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Equities researchers at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for Tyra Biosciences in a research report issued to clients and investors on Monday, May 19th. HC Wainwright analyst M. Kapoor anticipates that the com
FY2025 EPS Forecast for Tyra Biosciences Boosted by Analyst
Tyra Biosciences, Inc. stock logo
Vestal Point Capital LP Makes New Investment in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Vestal Point Capital LP bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 990,000 shares of the company's stock, valued at approximately $13,761,000. Vest
Tyra Biosciences, Inc. stock logo
Dimensional Fund Advisors LP Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Dimensional Fund Advisors LP boosted its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 283.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 37,981 shares of the company's stock after acquiring an additional 28,074 shares durin
Tyra Biosciences, Inc. stock logo
Janus Henderson Group PLC Has $24.29 Million Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Janus Henderson Group PLC increased its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 63.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,746,320 shares o
Tyra Biosciences, Inc. stock logo
Jacobs Levy Equity Management Inc. Purchases Shares of 244,245 Tyra Biosciences, Inc. (NASDAQ:TYRA)
Jacobs Levy Equity Management Inc. purchased a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 244,245 shares of the comp
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Acquired by Orbimed Advisors LLC
Orbimed Advisors LLC increased its position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 91.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,470,086 shares of the company's stock after buying an additional 701,4
Tyra Biosciences, Inc. stock logo
Cubist Systematic Strategies LLC Takes $1.53 Million Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Cubist Systematic Strategies LLC bought a new stake in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 109,748 shares of the company's stock, valu
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Rating of "Buy" by Brokerages
Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) has been given a consensus recommendation of "Buy" by the six brokerages that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target am
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Tyra Biosciences (NASDAQ:TYRA - Get Free Report) posted its earnings results on Thursday. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.49) by $0.02.
Tyra Biosciences, Inc. stock logo
Farallon Capital Management LLC Invests $13.91 Million in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Farallon Capital Management LLC bought a new stake in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,000,981 shares of the comp
Tyra Biosciences, Inc. stock logo
54,783 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 54,783 shares of the company's stock, valued at approximately $761,000. Raymond James Fi
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by BVF Inc. IL
BVF Inc. IL trimmed its holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 15.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,944,194 shares of the company's stock afte
Tyra Biosciences, Inc. stock logo
Susquehanna Fundamental Investments LLC Invests $543,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Susquehanna Fundamental Investments LLC acquired a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 39,093 shares of the company's stock, valued at approximat
Tyra Biosciences, Inc. stock logo
29,100 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Renaissance Technologies LLC
Renaissance Technologies LLC acquired a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 29,100 shares of the company's stock,
Tyra Biosciences, Inc. stock logo
Ally Bridge Group NY LLC Cuts Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Ally Bridge Group NY LLC cut its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 35.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 175,063 shares of the company's stock after selling 95,012 shares d
Tyra Biosciences, Inc. stock logo
Boxer Capital Management LLC Buys Shares of 2,027,678 Tyra Biosciences, Inc. (NASDAQ:TYRA)
Boxer Capital Management LLC purchased a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,027,678 shares of the company's stock, v
Tyra Biosciences, Inc. stock logo
Marshall Wace LLP Acquires 34,463 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)
Marshall Wace LLP grew its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 175.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,077 shares of the company's stock after purchasin
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by RA Capital Management L.P.
RA Capital Management L.P. raised its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,637,290 shares of the company's sto
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (TYRA) to Release Earnings on Thursday
Tyra Biosciences (NASDAQ:TYRA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-tyra-biosciences-inc-stock/)
Tyra Biosciences, Inc. stock logo
Nantahala Capital Management LLC Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Nantahala Capital Management LLC bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 100,000 shares of the company's stock, valued at approximately $1,3
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered its holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 75.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,115 shares of the company's stock after selli
Tyra Biosciences, Inc. stock logo
Walleye Capital LLC Sells 63,617 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)
Walleye Capital LLC decreased its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 50.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 62,980 shares of the company's stock after selling 63,617 shares during the period. Walle
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have been assigned an average rating of "Buy" from the six analysts that are presently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target
Tyra Biosciences, Inc. stock logo
Vanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)
Vanguard Group Inc. reduced its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 3.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,207,765 shares of the company's stock after selling 37,643 sha
Tyra Biosciences, Inc. stock logo
Investment Counsel Co. of Nevada Purchases New Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Investment Counsel Co. of Nevada acquired a new position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 85,020 shares of the company's s
Tyra Biosciences, Inc. stock logo
Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Raymond James Financial Inc. purchased a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 54,783 shares of the company's stock, valued at approx
Tyra Biosciences, Inc. stock logo
HC Wainwright Expects Lower Earnings for Tyra Biosciences
Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Investment analysts at HC Wainwright dropped their Q1 2025 EPS estimates for shares of Tyra Biosciences in a report released on Monday, March 31st. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($0.56) per
Tyra Biosciences, Inc. stock logo
Pictet Asset Management Holding SA Takes $4.92 Million Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Pictet Asset Management Holding SA bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 354,012 shares of the company's stock, valued at approxim
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Earns "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $30.00 target price on shares of Tyra Biosciences in a research report on Monday.
Tyra Biosciences, Inc. stock logo
What is Wedbush's Estimate for TYRA FY2029 Earnings?
Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings per share estimates for shares of Tyra Biosciences in a research note issued to investors on Friday, March 28th. Wedbush analyst R. Driscoll expects that the company will post earnings per
Tyra Biosciences price target lowered to $28 from $29 at BofA
Tyra Biosciences, Inc. stock logo
Tyra Biosciences' (TYRA) "Outperform" Rating Reiterated at Wedbush
Wedbush restated an "outperform" rating and issued a $30.00 target price on shares of Tyra Biosciences in a research note on Friday.
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up Following Better-Than-Expected Earnings
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up Following Strong Earnings
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Issues Earnings Results, Beats Estimates By $0.05 EPS
Tyra Biosciences (NASDAQ:TYRA - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.43) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.05.
Tyra Biosciences reports Q4 EPS (43c) vs. (53c) last year
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year Low - Here's What Happened
Tyra Biosciences (NASDAQ:TYRA) Sets New 52-Week Low - Time to Sell?
Tyra Biosciences, Inc. stock logo
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Buy" by Analysts
Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have received a consensus recommendation of "Buy" from the six analysts that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-
Tyra Biosciences, Inc. stock logo
Victory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)
Victory Capital Management Inc. boosted its position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 88.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,640 shares of the compa
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.7% - Should You Sell?
Tyra Biosciences (NASDAQ:TYRA) Shares Down 4.7% - Time to Sell?
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase - Here's What Happened
Tyra Biosciences (NASDAQ:TYRA) Sees Strong Trading Volume - Here's What Happened
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (NASDAQ:TYRA) Reaches New 12-Month Low - Time to Sell?
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year Low - Here's Why
Tyra Biosciences, Inc. stock logo
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Tuesday
Tyra Biosciences (NASDAQ:TYRA) will be releasing earnings before the market opens on Tuesday, March 18, Financial Modeling Prep reports.
Get Tyra Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter.

TYRA Media Mentions By Week

TYRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TYRA
News Sentiment

1.14

1.03

Average
Medical
News Sentiment

TYRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TYRA Articles
This Week

11

4

TYRA Articles
Average Week

Get Tyra Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TYRA) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners